Bispecific T cell engagers: an emerging therapy for management of hematologic malignancies

Harnessing the power of immune cells, especially T cells, to enhance anti-tumor activities has become a promising strategy in clinical management of hematologic malignancies. The emerging bispecific antibodies (BsAbs), which recruit T cells to tumor cells, exemplified by bispecific T cell engagers (...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Zheng, Liu, Ming, Zhang, Ya, Wang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091790/
https://www.ncbi.nlm.nih.gov/pubmed/33941237
http://dx.doi.org/10.1186/s13045-021-01084-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091790/
https://www.ncbi.nlm.nih.gov/pubmed/33941237
http://dx.doi.org/10.1186/s13045-021-01084-4

Ejemplares similares